Malignant melanoma is a life-threatening form of skin cancer with a low response rate to single-agent chemotherapy.
Scientific Publications
The efficacy of anti-programmed cell death protein 1 therapy among patients with metastatic acral and metastatic mucosal melanoma
This study was undertaken to explore the effectiveness of anti?programmed cell death protein 1 therapy among patients with metastatic acral and metastatic mucosal melanoma.
Bacterial peptides presented on tumour cells could be immunotherapy targets
Human tumours are colonized by microorganisms, collectively called the tumour microbiota, that can affect the microenvironment of the tumour – for example, by causing inflammation or local immune suppression.
Efficiency of detecting new primary melanoma among individuals treated in a high-risk clinic for skin surveillance
In this prospective cohort study involving 593 participants who were assessed as having a very high risk of melanoma from 2012 to 2018, researchers sought to investigate longer-term sustainability and expansion of the surveillance program to numerous practices, including a primary care skin cancer clinic setting.